SELEPARINA

Medicinal product

(Invented) name

SELEPARINA

Active substance (s)

Nadroparino kalcio druska

Strength

5700 anti-Xa TV/0,6 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AB06, Nadroparin

Marketing authorisation holder

UAB Edupharma, Lietuva

Date of authorisation

2021-06-29

Date of renewal

Documents

1549_1551_Seleparina_2023-03-15.docx

1551_Seleparina_PZ_2021-10-28.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

0,6 ml tirpalo yra:	0.6 ml
Nadroparino kalcio druska	5700 anti-Xa TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106751	92854	1092854	užpildytas švirkštas	0,6 ml N10		Receptinis	LT/L/21/1551/001	Netiekiama	2025-01-10	2025-12-31	No	-	-	Download

Stadijos

Data	Stadija
2021-06-29	Registruotas